Literature DB >> 1905796

Antiretinal antibodies in serum of patients with age-related macular degeneration.

D H Gurne1, M O Tso, D P Edward, H Ripps.   

Abstract

Antibodies, immunoreactive with normal human retinal proteins, were detected by Western immunoblot analysis in the sera of 30 patients with age-related macular degeneration (AMD). Sera from 14 of these patients demonstrated positive binding predominantly to a doublet protein of molecular weight between 58 and 62 kD. The sera from the remaining 16 patients and from 12 control subjects reacted either weakly or not at all with the doublet protein. No correlation was found with any specific type of AMD. The serum antibodies also immunocrossreacted with the same proteins from isolated photoreceptor outer segments; this was confirmed by indirect immunofluorescence on intact retinas. The crossreactivity of the serum antibodies with a protein of Mr 58 to 62 kD, the lower band present in the bovine purified neurofilament-68 kD preparation, suggests strongly that this protein may be a component of the neuronal cytoskeleton. However, it is not clear whether these autoantibodies play a direct role in the etiology of AMD or represent a nonspecific response to retinal damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905796     DOI: 10.1016/s0161-6420(91)32252-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

Review 1.  Retinopathies associated with antiretinal antibodies.

Authors:  J J Hooks; M O Tso; B Detrick
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 2.  Keypathophysiologic pathways in age-related macular disease.

Authors:  Felix Roth; Almut Bindewald; Frank G Holz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

3.  Deletion of aryl hydrocarbon receptor AHR in mice leads to subretinal accumulation of microglia and RPE atrophy.

Authors:  Soo-Young Kim; Hyun-Jin Yang; Yi-Sheng Chang; Jung-Woong Kim; Matthew Brooks; Emily Y Chew; Wai T Wong; Robert N Fariss; Rivka A Rachel; Tiziana Cogliati; Haohua Qian; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

Review 4.  The need for standardization of antiretinal antibody detection and measurement.

Authors:  Farzin Forooghian; Ian M Macdonald; John R Heckenlively; Elise Héon; Lynn K Gordon; John J Hooks; Barbara Detrick; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

5.  Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations.

Authors:  J R Heckenlively; N Aptsiauri; S Nusinowitz; C Peng; P A Hargrave
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 6.  Statins for age-related macular degeneration.

Authors:  Peter Gehlbach; Tianjing Li; Elham Hatef
Journal:  Cochrane Database Syst Rev       Date:  2015-02-11

Review 7.  Statins for age-related macular degeneration.

Authors:  Peter Gehlbach; Tianjing Li; Elham Hatef
Journal:  Cochrane Database Syst Rev       Date:  2016-08-04

Review 8.  Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration?

Authors:  Grazyna Adamus
Journal:  Autoimmun Rev       Date:  2017-01-28       Impact factor: 9.754

9.  Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration.

Authors:  P L Penfold; L Wen; M C Madigan; M C Gillies; N J King; J M Provis
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 10.  Statins for age-related macular degeneration.

Authors:  Peter Gehlbach; Tianjing Li; Elham Hatef
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.